Abstract:CYP2C9 is one of the most abundant CYP enzymes in the human liver ( approximately 20% of hepatic total CYP content). CYP2C9 metabolizes approximately 20% clinical drugs (>120 drugs), including a number of drugs with narrow therapeutic ranges. Some natural compounds are also metabolized, probably leading to the formation of toxic metabolites. CYP2C9 also plays a role in the metabolism of several endogenous compounds such as steroids, melatonin, retinoids and arachidonic acid. Typical substrates of CYP2C9 such as celecoxib, ibuprofen, flurbiprofen, and diclofenac are relatively small, lipophilic and contain acidic groupings with pK(a) values in the range 3.8-8.1 which will be ionized at physiological pH. The carboxylate groups of tienilic acid and diclofenac have been shown to be responsible for substrate preference and orientation in the active site of CYP2C9. Therefore, a typical CYP2C9 substrate should contain an anionic site and a hydrophobic site. However, neutral or positively charged compounds may also be substrates of CYP2C9. CYP2C9 is subject to inhibition by a number of drugs and other compounds and this may provide an explanation for some clinical drug-drug interactions. With regard to prodrugs that need CYP2C9 for activation, inhibition of CYP2C9 may cause a decrease in the amount of the active metabolite, leading to therapeutic failure. Pharmacophore models have revealed that hydrogen bonding, ion-pair interactions, and probably hydrophobic interactions play a major role in determining the substrate specificity and inhibitor selectivity of CYP2C9. A number of structure-activity relationship studies have identified the structural determinants of compounds for their binding affinity to CYP2C9 and inhibitory potency for CYP2C9. Given the critical role of CYP2C9 in drug metabolism and the presence of polymorphisms, it is important to identify drug candidates as potential substrates and/or inhibitors of CYP2C9 in drug development and drugs with minimal interactions with this enzyme should be chosen for further development. Further studies are warranted to explore the molecular determinants for ligand-CYP2C9 binding and the structure-activity relationships.

Investigation of the role of cytochrome P450 2B4 active site residues in substrate metabolism based on crystal structures of the ligand-bound enzyme

Investigation Of The Role Of Cytochrome P4502b4 Active Site Residues In Substrate Metabolism Based On Crystal Structures Of The Ligand-Bound Enzyme

Substrate Routes to the Buried Active Site May Vary among Cytochromes P450: Mutagenesis of the F−G Region in P450 2B1

Structural dynamics of cytochrome P450 3A4 in the presence of substrates and cytochrome P450 reductase

Multiresolution molecular dynamics simulations reveal the interplay between conformational variability and functional interactions in membrane‐bound cytochrome P450 2B4

Coumarin Derivatives as Substrate Probes of Mammalian Cytochromes P450 2B4 and 2B6: Assessing the Importance of 7-Alkoxy Chain Length, Halogen Substitution, and Non-Active Site Mutations

The Crystal Structures Of 4-Methoxybenzoate Bound Cyp199a2 And Cyp199a4: Structural Changes On Substrate Binding And The Identification Of An Anion Binding Site

Molecular Determinants of Substrate Affinity and Enzyme Activity of a Cytochrome P450BM3 Variant

Multiresolution molecular dynamics simulations reveal the interplay between conformational variability and functional interactions in membrane-bound cytochrome 2B4

Structure, Electronic Properties and Catalytic Behaviour of an Activity-Enhancing CYP102A1 (P450BM3) Variant

The use of isomeric testosterone dimers to explore allosteric effects in substrate binding to cytochrome P450 CYP3A4

New Insights into the Structural Features and Functional Relevance of Human Cytochrome P450 2C9. Part I.

Unraveling the Structural Basis of Selective Inhibition of Human Cytochrome P450 3A5

Analysis of clinically relevant substrates of CYP2B6 enzyme by computational methods

Exploring the structure characteristics and major channels of cytochrome P450 2A6, 2A13, and 2E1 with pilocarpine.

Functional Characterization and Mechanistic Modeling of the Human Cytochrome P450 Enzyme CYP4A22

New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme

Three-Dimensional Quantitative Structure Activity Relationship for Cyp2d6 Substrates

Mutagenesis and Molecular Dynamics Suggest Structural and Functional Roles for Residues in the N-terminal Portion of the Cytochrome P450 2B1 I Helix

Efficient Substrate Screening and Inhibitor Testing of Human CYP4Z1 Using Permeabilized Recombinant Fission Yeast

Molecular Modeling of Cytochrome P450 2B1: Mode of Membrane Insertion and Substrate Specificity.